Stock Evaluator: The Cooper Companies, Inc. (COO)

The Cooper Companies, Inc. COO

$72.32 -0.33 -0.45%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 2,518,505
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Commentary & Analysis


Financial Summary

Share Statistics COO Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $14,169.0 $334.8 82%
Shares Out (Mil) 195.0 41.7 76%
Institutional Ownership 99.4% 77.3% 88%
Float (Mil) 193.7 34.7 74%
Beta 0.87 0.86 52%
Avg Daily Volume (000s) 1,868 266 81%
Price Change
(52-week)
(1.4%) 60.7% 44%
Growth COO Industry
Median
Percentile
(All Stocks)
Sales (5yr) 11.0% 11.8% 62%
Net Income (5yr) 9.5% (5.8%) 54%
EPS (5yr) 9.2% 10.7% 45
Dividends (5yr) (14.9%) 0.0% 0%
Cash Flow (5yr) (41.0%) (16.1%) 11%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 15 16 16
Current EPS $1.121 $4.628 $4.996
Month Ago EPS $1.120 $4.628 $4.997
# Rev Up 0 1 1
# Rev Down 1 0 1
Three Months Ago EPS $1.190 $4.617 $5.020
Year/Year Chg (380.3%) 147.5% 190.2%
Financials COO Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $4,231 $152 72%
Net Income (TTM) (Mil) $236 ($11) 70%
EPS (TTM) $1.198 ($0.500) 63%
Operating Cash Flow (TTM) (Mil) $953 ($2) 80%
Net Cash Flow (TTM) (Mil) $23 $1 64%
Long-Term Debt (Q1) (Mil) $2,128 $22 75%
Enterprise Value (Q1) (Mil) $16,439 $304 81%
Valuation COO Industry
Median
Percentile
(All Stocks)
P/B 1.72 2.88 45%
P/E 61.3 30.5 87%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 6.7 1.9 90%
Ratios COO Industry
Median
Percentile
(All Stocks)
Gross Margin 65.5% 59.1% 77%
Net Margin 5.6% (7.7%) 50%
ROA 1.9% (13.7%) 55%
ROE 2.9% (15.9%) 40%
Liabilities to Assets 34.0% 44.9% 25%
F-Score 6 4 69%

The Cooper Companies, Inc. did not pass any screens on 7/30/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors